Rebecca Taub Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 6 days, 14 hours ago
Rebecca Taub has an estimated net worth of at least $165.6 million*, as of March 5, 2025. They own 461,044 shares of MDGL stock. They have sold 78,901 shares of MDGL stock since 2021, for an estimated $19.4 million.
Rebecca Taub $MDGL SEC Form 4 Insider Trading
Rebecca Taub has filed a total of 27 insider trades in $MDGL since 2021. Their most recent trade was a sale of 648 shares, made on Jan 24, 2025. Their largest trade was a sale of 18,917 shares, made on Apr 03, 2024. We estimate that they now own 461,044 shares of $MDGL, worth an estimated $146.3 million.
Insider Trading at $MDGL
There have been a total of 351 insider trades reported at $MDGL since 2021, with 424,685 shares purchased and 418,747 shares sold. The most active insider traders in $MDGL stock have been Brian Joseph Lynch, Rebecca Taub, and Robert E. Waltermire. The most recent trade was a sale of 1,777 shares reported by Robert E. Waltermire (Senior VP, Chief Pharma Dev.), made on Mar 05, 2025.
History of Insider Stock Trades by Rebecca Taub
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
MDGL
|
Sale | 648 | Jan 24, 2025 | Jan. 27, 2025, 6:07 p.m. |
|
MDGL
|
Sale | 1,689 | Jan 17, 2025 | Jan. 17, 2025, 8:05 p.m. |
|
MDGL
|
Sale | 200 | Apr 08, 2024 | April 10, 2024, 8:53 p.m. |
|
MDGL
|
Sale | 224 | Apr 08, 2024 | April 10, 2024, 8:53 p.m. |
|
MDGL
|
Sale | 945 | Apr 08, 2024 | April 10, 2024, 8:53 p.m. |
|
MDGL
|
Sale | 300 | Apr 08, 2024 | April 10, 2024, 8:53 p.m. |
|
MDGL
|
Sale | 600 | Apr 08, 2024 | April 10, 2024, 8:53 p.m. |
|
MDGL
|
Sale | 407 | Apr 08, 2024 | April 10, 2024, 8:53 p.m. |
|
MDGL
|
Sale | 5,619 | Apr 04, 2024 | April 5, 2024, 8:50 p.m. |
|
MDGL
|
Sale | 3,085 | Apr 04, 2024 | April 5, 2024, 8:50 p.m. |
|
MDGL
|
Sale | 435 | Apr 04, 2024 | April 5, 2024, 8:50 p.m. |
|
MDGL
|
Sale | 2,734 | Apr 04, 2024 | April 5, 2024, 8:50 p.m. |
|
MDGL
|
Sale | 1,653 | Apr 04, 2024 | April 5, 2024, 8:50 p.m. |
|
MDGL
|
Sale | 711 | Apr 04, 2024 | April 5, 2024, 8:50 p.m. |
|
MDGL
|
Sale | 100 | Apr 04, 2024 | April 5, 2024, 8:50 p.m. |
|
MDGL
|
Sale | 1,643 | Apr 05, 2024 | April 5, 2024, 8:50 p.m. |
|
MDGL
|
Sale | 700 | Apr 05, 2024 | April 5, 2024, 8:50 p.m. |
|
MDGL
|
Sale | 8,817 | Apr 05, 2024 | April 5, 2024, 8:50 p.m. |
|
MDGL
|
Sale | 8,989 | Apr 05, 2024 | April 5, 2024, 8:50 p.m. |
|
MDGL
|
Sale | 2,079 | Apr 05, 2024 | April 5, 2024, 8:50 p.m. |
|
MDGL
|
Sale | 5,278 | Apr 05, 2024 | April 5, 2024, 8:50 p.m. |
|
MDGL
|
Sale | 135 | Apr 03, 2024 | April 5, 2024, 8:50 p.m. |
|
MDGL
|
Sale | 2,634 | Apr 03, 2024 | April 5, 2024, 8:50 p.m. |
|
MDGL
|
Sale | 4,070 | Apr 03, 2024 | April 5, 2024, 8:50 p.m. |
|
MDGL
|
Sale | 18,917 | Apr 03, 2024 | April 5, 2024, 8:50 p.m. |
|
MDGL
|
Sale | 2,089 | Apr 03, 2024 | April 5, 2024, 8:50 p.m. |
|
MDGL
|
Sale | 4,200 | Apr 04, 2024 | April 5, 2024, 8:50 p.m. |
$MDGL Executives and Stock Owners with Insider Trades
-
Brian Joseph Lynch, SVP and General Counsel
-
Rebecca Taub, Pres., R&D, and CMO
-
Robert E. Waltermire, Senior VP, Chief Pharma Dev.
-
Remy Sukhija, Chief Commercial Officer
-
Carole Huntsman, Chief Commercial Officer
-
Mardi Dier, SVP and CFO
-
Shannon T Kelley, General Counsel
-
William John Sibold, President and CEO
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.